Clinical Trial Update: Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen [Phase 3]

View source ↗

Summary

Phase 3 trial assessing in-home administration of evolocumab (AMG 145) using automated mini-doser or prefilled autoinjector/pen in patients with primary hyperch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Amgen | Conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2015-12-23